185 related articles for article (PubMed ID: 32447501)
1. Genetic markers for treatment-related pancreatitis in a cohort of Hispanic children with acute lymphoblastic leukemia.
Grimes AC; Chen Y; Bansal H; Aguilar C; Perez Prado L; Quezada G; Estrada J; Tomlinson GE
Support Care Cancer; 2021 Feb; 29(2):725-731. PubMed ID: 32447501
[TBL] [Abstract][Full Text] [Related]
2. Trypsin-encoding
Wolthers BO; Frandsen TL; Patel CJ; Abaji R; Attarbaschi A; Barzilai S; Colombini A; Escherich G; Grosjean M; Krajinovic M; Larsen E; Liang DC; Möricke A; Rasmussen KK; Samarasinghe S; Silverman LB; van der Sluis IM; Stanulla M; Tulstrup M; Yadav R; Yang W; Zapotocka E; Gupta R; Schmiegelow K;
Haematologica; 2019 Mar; 104(3):556-563. PubMed ID: 30467200
[TBL] [Abstract][Full Text] [Related]
3. Asparaginase-associated pancreatitis in childhood acute lymphoblastic leukaemia: an observational Ponte di Legno Toxicity Working Group study.
Wolthers BO; Frandsen TL; Baruchel A; Attarbaschi A; Barzilai S; Colombini A; Escherich G; Grell K; Inaba H; Kovacs G; Liang DC; Mateos M; Mondelaers V; Möricke A; Ociepa T; Samarasinghe S; Silverman LB; van der Sluis IM; Stanulla M; Vrooman LM; Yano M; Zapotocka E; Schmiegelow K;
Lancet Oncol; 2017 Sep; 18(9):1238-1248. PubMed ID: 28736188
[TBL] [Abstract][Full Text] [Related]
4. Clinical and Genetic Risk Factors for Acute Pancreatitis in Patients With Acute Lymphoblastic Leukemia.
Liu C; Yang W; Devidas M; Cheng C; Pei D; Smith C; Carroll WL; Raetz EA; Bowman WP; Larsen EC; Maloney KW; Martin PL; Mattano LA; Winick NJ; Mardis ER; Fulton RS; Bhojwani D; Howard SC; Jeha S; Pui CH; Hunger SP; Evans WE; Loh ML; Relling MV
J Clin Oncol; 2016 Jun; 34(18):2133-40. PubMed ID: 27114598
[TBL] [Abstract][Full Text] [Related]
5. [Acute pancreatitis in children with acute lymphoblastic leukemia treated with L-asparaginase].
Wlazłowski M; Celińska W; Maciejka-Kapuścińska L; Płoszyńska A; Idczak E
Pol Tyg Lek; 1994 Mar 21-28; 49(12-13):296-7. PubMed ID: 7808958
[TBL] [Abstract][Full Text] [Related]
6. Clinical course and outcome in children with acute lymphoblastic leukemia and asparaginase-associated pancreatitis.
Kearney SL; Dahlberg SE; Levy DE; Voss SD; Sallan SE; Silverman LB
Pediatr Blood Cancer; 2009 Aug; 53(2):162-7. PubMed ID: 19405141
[TBL] [Abstract][Full Text] [Related]
7. L-asparaginase (Leunase) induced pancreatitis in childhood acute lymphoblastic leukemia.
Sahu S; Saika S; Pai SK; Advani SH
Pediatr Hematol Oncol; 1998; 15(6):533-8. PubMed ID: 9842647
[TBL] [Abstract][Full Text] [Related]
8. Acute pancreatitis in children with acute lymphoblastic leukemia correlates with L-asparaginase dose intensity.
Chen CB; Chang HH; Chou SW; Yang YL; Lu MY; Jou ST; Chen HL; Ni YH; Lin DT; Chang MH; Wu JF
Pediatr Res; 2022 Aug; 92(2):459-465. PubMed ID: 34718353
[TBL] [Abstract][Full Text] [Related]
9. Serial Ultrasound Monitoring for Early Recognition of Asparaginase Associated Pancreatitis in Children With Acute Lymphoblastic Leukemia.
Raja RA; Schmiegelow K; Henriksen BM; Leth Frandsen T
Pediatr Hematol Oncol; 2015; 32(7):474-81. PubMed ID: 26270775
[TBL] [Abstract][Full Text] [Related]
10. Polymorphisms of asparaginase pathway and asparaginase-related complications in children with acute lymphoblastic leukemia.
Ben Tanfous M; Sharif-Askari B; Ceppi F; Laaribi H; Gagné V; Rousseau J; Labuda M; Silverman LB; Sallan SE; Neuberg D; Kutok JL; Sinnett D; Laverdière C; Krajinovic M
Clin Cancer Res; 2015 Jan; 21(2):329-34. PubMed ID: 24907114
[TBL] [Abstract][Full Text] [Related]
11. Octreotide therapy in asparaginase-associated pancreatitis in childhood acute lymphoblastic leukemia.
Wu SF; Chen AC; Peng CT; Wu KH
Pediatr Blood Cancer; 2008 Dec; 51(6):824-5. PubMed ID: 18726919
[TBL] [Abstract][Full Text] [Related]
12. Intermittent Versus Continuous PEG-Asparaginase to Reduce Asparaginase-Associated Toxicities: A NOPHO ALL2008 Randomized Study.
Albertsen BK; Grell K; Abrahamsson J; Lund B; Vettenranta K; Jónsson ÓG; Frandsen TL; Wolthers BO; Heyman M; Schmiegelow K
J Clin Oncol; 2019 Jul; 37(19):1638-1646. PubMed ID: 30978155
[TBL] [Abstract][Full Text] [Related]
13. Whole-exome sequencing identified genetic risk factors for asparaginase-related complications in childhood ALL patients.
Abaji R; Gagné V; Xu CJ; Spinella JF; Ceppi F; Laverdière C; Leclerc JM; Sallan SE; Neuberg D; Kutok JL; Silverman LB; Sinnett D; Krajinovic M
Oncotarget; 2017 Jul; 8(27):43752-43767. PubMed ID: 28574850
[TBL] [Abstract][Full Text] [Related]
14. Incidence of asparaginase-related hepatotoxicity, pancreatitis, and thrombotic events in adults with acute lymphoblastic leukemia treated with a pediatric-inspired regimen.
Christ TN; Stock W; Knoebel RW
J Oncol Pharm Pract; 2018 Jun; 24(4):299-308. PubMed ID: 28355969
[TBL] [Abstract][Full Text] [Related]
15. Acute pancreatitis in children with acute lymphoblastic leukemia after chemotherapy.
Treepongkaruna S; Thongpak N; Pakakasama S; Pienvichit P; Sirachainan N; Hongeng S
J Pediatr Hematol Oncol; 2009 Nov; 31(11):812-5. PubMed ID: 19801948
[TBL] [Abstract][Full Text] [Related]
16. Pegaspargase-induced pancreatitis.
Alvarez OA; Zimmerman G
Med Pediatr Oncol; 2000 Mar; 34(3):200-5. PubMed ID: 10696127
[TBL] [Abstract][Full Text] [Related]
17. Asparaginase-Associated Pancreatitis in Acute Lymphoblastic Leukemia: Results From the NOPHO ALL2008 Treatment of Patients 1-45 Years of Age.
Rank CU; Wolthers BO; Grell K; Albertsen BK; Frandsen TL; Overgaard UM; Toft N; Nielsen OJ; Wehner PS; Harila-Saari A; Heyman MM; Malmros J; Abrahamsson J; Norén-Nyström U; Tomaszewska-Toporska B; Lund B; Jarvis KB; Quist-Paulsen P; Vaitkevičienė GE; Griškevičius L; Taskinen M; Wartiovaara-Kautto U; Lepik K; Punab M; Jónsson ÓG; Schmiegelow K
J Clin Oncol; 2020 Jan; 38(2):145-154. PubMed ID: 31770057
[TBL] [Abstract][Full Text] [Related]
18. Can Machine Learning Models Predict Asparaginase-associated Pancreatitis in Childhood Acute Lymphoblastic Leukemia.
Nielsen RL; Wolthers BO; Helenius M; Albertsen BK; Clemmensen L; Nielsen K; Kanerva J; Niinimäki R; Frandsen TL; Attarbaschi A; Barzilai S; Colombini A; Escherich G; Aytan-Aktug D; Liu HC; Möricke A; Samarasinghe S; van der Sluis IM; Stanulla M; Tulstrup M; Yadav R; Zapotocka E; Schmiegelow K; Gupta R
J Pediatr Hematol Oncol; 2022 Apr; 44(3):e628-e636. PubMed ID: 35226426
[TBL] [Abstract][Full Text] [Related]
19. Asparaginase toxicity in Hispanic adult and pediatric patients with acute lymphoblastic leukemia: current understanding.
Alqahtani A; Alhousari D; Ali A; Yaghmour G; Orgel E; Curran E; Stock W; Bhojwani D; Alachkar H
Expert Opin Drug Metab Toxicol; 2023; 19(6):357-366. PubMed ID: 37410014
[TBL] [Abstract][Full Text] [Related]
20. Influence of genetic variants in asparaginase pathway on the susceptibility to asparaginase-related toxicity and patients' outcome in childhood acute lymphoblastic leukemia.
Youssef YH; Makkeyah SM; Soliman AF; Meky NH
Cancer Chemother Pharmacol; 2021 Aug; 88(2):313-321. PubMed ID: 33959786
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
